New York's Office-to-Home Gold Rush Is Hitting Its First Real Wall

Developers sprinted to flip Manhattan's empty towers into apartments after the pandemic hollowed out commercial real estate — now a troubled conversion project is raising questions about whether the math ever added up.

New York City's office-conversion pipeline accelerated sharply after 2020 as remote work cratered demand for commercial space.
The former Pfizer headquarters building has emerged as a cautionary example, with its conversion project facing significant financial stress.
Adaptive reuse of older office towers is technically complicated and expensive, with floor-plate depths and core layouts often ill-suited to residential units.
City and state incentives were designed to accelerate conversions, but incentives do not offset structural construction risk.
Industry observers now expect a thinning of the conversion herd, with only the most straightforward — and best-capitalized — projects completing on schedule.

For a couple of years there, converting a vacant Midtown office tower into apartments sounded like the cleanest trade in New York real estate. Commercial vacancy was running at historic highs. Housing demand was not. The city was dangling tax incentives. Architects were pitching renders of sun-filled studios where the cubicles used to be. The logic wrote itself.

Now the Pfizer building is writing a different kind of story. The former pharmaceutical giant's Manhattan headquarters — a mid-century tower that once housed one of the most valuable drug pipelines in the world — is at the center of what Curbed reported this week as a conversion project showing serious signs of strain. The piece, published Wednesday, positions the building as a possible bellwether for a broader reckoning inside the office-to-residential boom.

The structural problem with office conversions has always been hiding in the floor plates. Older commercial towers were built deep — sometimes 60 or 70 feet from window to core — because natural light was an afterthought when you were running a trading floor or a secretarial pool. Residential buildings need windows in every unit. Cutting light wells into reinforced concrete costs money that pro formas written in 2022 may not have fully absorbed.

Add rising construction costs, interest rates that have stayed higher longer than developers modeled, and a city permitting process that moves at its own pace, and the conversion arithmetic gets uncomfortable fast.

None of this means the pipeline collapses. New York added roughly 1,200 units through office conversion last year, according to figures circulating in the trade press, and several projects are delivering on time. But the Pfizer building's difficulties suggest the easy deals — the pre-war towers with shallow floor plates and cooperative lenders — may already be spoken for. What remains is harder. The asking prices on some of these conversion condos will need to reflect that.